Glycosylation is a key in SARS-CoV-2 infection
Open Access
- 22 May 2021
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 99 (8) , 1023-1031
Abstract
SARS-CoV-2 causes the respiratory syndrome COVID-19 and is responsible for the current pandemic. The S protein of SARS-CoV-2-mediating virus binding to target cells and subsequent viral uptake is extensively glycosylated. Here we focus on how glycosylation of both SARS-CoV-2 and target cells crucially impacts SARS-CoV-2 infection at different levels: (1) virus binding and entry to host cells, with glycosaminoglycans of host cells acting as a necessary co-factor for SARS-CoV-2 infection by interacting with the receptor-binding domain of the SARS-CoV-2 spike glycoprotein, (2) innate and adaptive immune response where glycosylation plays both a protective role and contributes to immune evasion by masking of viral polypeptide epitopes and may add to the cytokine cascade via non-fucosylated IgG, and (3) therapy and vaccination where a monoclonal antibody-neutralizing SARS-CoV-2 was shown to interact also with a distinct glycan epitope on the SARS-CoV-2 spike protein. These evidences highlight the importance of ensuring that glycans are considered when tackling this disease, particularly in the development of vaccines, therapeutic strategies and serological testing.Keywords
Funding Information
- Charité - Universitätsmedizin Berlin
This publication has 51 references indexed in Scilit:
- Glycosylation-directed quality control of protein foldingNature Reviews Molecular Cell Biology, 2015
- Adaptive immune activation: glycosylation does matterNature Chemical Biology, 2013
- N-Glycan Analysis of Recombinant L-Selectin Reveals Sulfated GalNAc and GalNAc−GalNAc MotifsJournal of Proteome Research, 2010
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus EntryJournal of Virology, 2007
- Protein N-Glycosylation in the Baculovirus-Insect Cell SystemCurrent Drug Targets, 2007
- The Cytoplasmic Tail of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains a Novel Endoplasmic Reticulum Retrieval Signal That Binds COPI and Promotes Interaction with Membrane ProteinJournal of Virology, 2007
- Galectin-1 Acts as a Soluble Host Factor That Promotes HIV-1 Infectivity through Stabilization of Virus Attachment to Host CellsThe Journal of Immunology, 2005
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Antibody neutralization and escape by HIV-1Nature, 2003